2.2. Analysis.
Comparison 2: Subgroup analysis: Effects on mortality up to day 28, Outcome 2: Subgroup analysis: concomitant therapeutic dose anticoagulation or prophylactic anticoagulation
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.